|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,660,525 |
|
|
Indirect Value
|
$12,932,114,466 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,013,774,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 52 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2016-08-15 |
4 |
S |
$4.83 |
$1,931,040 |
I/I |
(400,000) |
9,419,240 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-09 |
4 |
B |
$26.66 |
$1,941,654 |
I/I |
72,479 |
6,348,720 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-28 |
4 |
S |
$19.90 |
$1,955,461 |
I/I |
(97,439) |
1,648,599 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-02 |
4 |
B |
$26.00 |
$1,956,372 |
I/I |
74,969 |
5,253,682 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-01 |
4 |
B |
$27.47 |
$1,964,575 |
I/I |
71,471 |
5,855,797 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-17 |
4 |
S |
$15.43 |
$1,977,056 |
I/I |
(128,066) |
3,952,047 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-13 |
4 |
S |
$15.30 |
$1,997,341 |
I/I |
(130,472) |
1,856,449 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-07 |
4 |
B |
$9.48 |
$2,012,667 |
I/I |
212,282 |
4,787,720 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-11-07 |
4 |
B |
$7.27 |
$2,030,532 |
I/I |
279,134 |
4,231,181 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-10 |
4 |
B |
$29.86 |
$2,051,783 |
I/I |
68,681 |
234,540 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-12-19 |
4 |
B |
$11.14 |
$2,058,449 |
I/I |
184,780 |
1,646,964 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-08 |
4 |
B |
$10.00 |
$2,069,012 |
I/I |
190,709 |
2,984,789 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-21 |
4 |
B |
$25.91 |
$2,071,986 |
I/I |
79,984 |
6,670,197 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$2,123,675 |
I/I |
339,788 |
4,966,001 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$2,135,616 |
I/I |
(98,334) |
1,746,038 |
|
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-06 |
4 |
S |
$8.17 |
$2,154,200 |
I/I |
(263,547) |
2,022,293 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-09-06 |
4 |
B |
$17.00 |
$2,206,641 |
I/I |
129,187 |
14,776,080 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$2,219,644 |
I/I |
355,143 |
15,131,223 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-28 |
4 |
S |
$19.90 |
$2,231,505 |
I/I |
(111,194) |
1,957,127 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-09 |
4 |
B |
$26.25 |
$2,360,109 |
I/I |
89,891 |
6,059,449 |
2.25 |
- |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-06-06 |
4 |
B |
$7.75 |
$2,361,093 |
I/I |
303,917 |
15,967,504 |
2.25 |
% |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-22 |
4 |
B |
$16.67 |
$2,382,705 |
I/I |
142,938 |
1,017,895 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2011-12-09 |
4 |
B |
$13.19 |
$2,402,409 |
I/I |
181,201 |
11,887,544 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-13 |
4 |
B |
$5.45 |
$2,404,792 |
I/I |
440,623 |
6,927,155 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$2,437,148 |
I/I |
(112,218) |
2,068,321 |
|
- |
|
1397 Records found
|
|
Page 52 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|